Hard-To-Treat Myc-Driven Cancers May Be Susceptible to Drug Already Used in ... Science Daily (press release) McArthur and his colleagues tested their hypothesis in a mouse model of Myc-driven lymphoma and found that treatment with everolimus provided strong protection against disease: only four of 33 mice treated with everolimus developed lymphoma, while 22 ... |
